Your browser is no longer supported. Please, upgrade your browser.
GlaxoSmithKline plc
Index- P/E18.05 EPS (ttm)2.65 Insider Own- Shs Outstand2.44B Perf Week0.21%
Market Cap116.48B Forward P/E17.08 EPS next Y2.80 Insider Trans- Shs Float2.40B Perf Month10.39%
Income6.46B PEG- EPS next Q- Inst Own10.00% Short Float0.27% Perf Quarter3.42%
Sales36.61B P/S3.18 EPS this Y22.30% Inst Trans-5.78% Short Ratio1.55 Perf Half Y1.85%
Book/sh3.23 P/B14.80 EPS next Y1.27% ROA10.40% Target Price46.36 Perf Year-10.63%
Cash/sh2.64 P/C18.14 EPS next 5Y- ROE67.60% 52W Range40.65 - 53.67 Perf YTD13.53%
Dividend2.78 P/FCF- EPS past 5Y4.60% ROI24.90% 52W High-11.33% Beta0.64
Dividend %5.81% Quick Ratio0.70 Sales past 5Y1.70% Gross Margin69.40% 52W Low17.08% ATR0.59
Employees99817 Current Ratio1.00 Sales Q/Q-10.00% Oper. Margin24.30% RSI (14)67.29 Volatility1.02% 1.04%
OptionableYes Debt/Eq3.76 EPS Q/Q-59.00% Profit Margin17.60% Rel Volume0.54 Prev Close47.82
ShortableYes LT Debt/Eq2.70 Earnings- Payout91.80% Avg Volume4.22M Price47.59
Recom2.80 SMA201.86% SMA507.16% SMA2002.56% Volume1,885,313 Change-0.48%
Feb-19-15Reiterated Argus Buy $55 → $52
Aug-08-14Reiterated Argus Buy $65 → $55
Apr-23-14Upgrade Argus Hold → Buy
May-28-13Upgrade Deutsche Bank Hold → Buy
Jan-11-11Upgrade Jefferies Hold → Buy
Jun-02-10Upgrade Jefferies Hold → Buy
Feb-16-10Upgrade JP Morgan Underweight → Neutral $26
Jan-13-10Downgrade Credit Suisse Outperform → Underperform
Nov-24-09Initiated Leerink Swann Mkt Perform
Nov-16-09Initiated Deutsche Securities Hold
Nov-12-09Initiated Barclays Capital Equal Weight
Oct-23-09Downgrade Jefferies & Co Buy → Hold
Mar-17-09Initiated Credit Suisse Outperform
Jan-26-09Initiated Jefferies & Co Buy
Nov-14-08Downgrade UBS Buy → Neutral
Apr-18-08Downgrade JP Morgan Neutral → Underweight
Feb-11-08Upgrade UBS Neutral → Buy
Feb-01-08Upgrade HSBC Securities Underweight → Neutral
Oct-24-07Initiated Bernstein Mkt Perform
Sep-06-07Initiated UBS Neutral
Mar-04-15 01:22PM  People Moves: News Corp, Merz North America, Wells Fargo Advisors at The Wall Street Journal
Mar-03-15 02:16PM  Has Orexigen Endangered Its Future To Boost Its Stock? at Forbes
07:08AM  5 Health Care Stocks to Trade for Breakout Gains in March at TheStreet
Mar-02-15 10:40AM  Isis Pharmaceuticals Up on Q4 Earnings and Revenues Beat - Analyst Blog Zacks
Feb-27-15 04:15PM  Interested In Pharmaceutical Stocks? Try Novartis (ADR) at Investopedia
Feb-26-15 02:53PM  What You Should Know Before Watching Vice's Special About Curing Cancer at Forbes
12:16PM  Glaxo Chief Wittys Compensation Cut 46% as Profit Declined at Bloomberg
09:00AM  Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors - Analyst Blog Zacks
Feb-25-15 01:15PM  GSK to be No. 1 vaccine producer when it completes $25B asset swap with Novartis next week at
11:47AM  GSK set to complete $20 billion Novartis asset swap next week Reuters
11:42AM  GSK set to complete $20 bln Novartis asset swap next week Reuters
10:30AM  Can Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog Zacks
09:48AM  [video]GlaxoSmithKlein's Diet Pill Alli Back in Stores After Recall at TheStreet
08:24AM  Nonprescription diet pill alli back in stores after recall AP
Feb-24-15 05:06PM  Big pharma diversifies business to mitigate patent risk Market Realist
02:27PM  Brain-Altering Devices May Supplant Drugs -- And Pharma Is OK With That at Forbes
12:56PM  In The Book Of Life, A Second Map Is Established at Forbes
Feb-23-15 05:15PM  Biotech battles 'Superbug' CNBC
Feb-19-15 05:27PM  Who can beat the 'superbug'? CNBC
09:22AM  Theravance Reports In Line Loss in Q4, Revenues Increase - Analyst Blog Zacks
Feb-18-15 10:59AM  Why Big Pharma Must Cure Its Bad Rap at Forbes
08:18AM  John Oliver's Big Pharma Rant Is Amusing -- But Misleading at Forbes
Feb-17-15 10:35AM  GlaxoSmithKline replaces Connelly; RTP exec Bailey to take over at American City Business Journals
08:30AM  Global Pharma's R&D Re-Balancing at Forbes
Feb-16-15 11:17AM  Glaxo Names Bailey to Replace Connelly Atop Ailing U.S. Unit Bloomberg
10:37AM  Glaxo Replaces Connelly With Jack Bailey Atop Ailing U.S. Unit at Bloomberg
Feb-13-15 10:41AM  Stocks Edge Higher Friday; Glaxo, Taiwan Semi Muscle Up at Investor's Business Daily
09:53AM  Cramer's Stop Trading: APA & GSK CNBC
Feb-10-15 02:21PM  GlaxoSmithKline (GSK) may IPO ViiV Healthcare in 2016 at Forbes
Feb-09-15 05:54PM  Glaxo Submits Another Revolade Application in the EU - Analyst Blog Zacks
05:36PM  Theravance/Glaxo's Asthma Drug Under FDA Panel Review - Analyst Blog Zacks
05:10AM  GSK and Theravance Announce Start of Phase III Lung Function Study With 'Closed' Triple Combination Treatment FF/UMEC/VI for COPD Marketwired
Feb-06-15 07:00AM  GlaxoSmithKline, plc (GSK): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-05-15 09:05AM  Glaxo Posts In Line Q4 Earnings, HIV Segment Sales Grow - Analyst Blog Zacks
Feb-04-15 04:20PM  GLAXOSMITHKLINE PLC (GSK) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
12:58PM  Glaxo Is Still in the Recovery Room at The Wall Street Journal
11:52AM  Strong HIV, Cancer Drugs Will Boost GlaxoSmithKline Stock at TheStreet
09:30AM  ViiV Healthcare Announces $10 Million Initiative to Accelerate Response to HIV/AIDS Among Black Gay and Bisexual Men PR Newswire
09:08AM  Glaxo Posts Sharp Fall in Profit at The Wall Street Journal
08:41AM  Staples buys Office Depot and Greece schmoozes for cash 5 things to know today at Fortune
08:39AM  Glaxo (GSK) Q4 Earnings in Line, Beats on Revenues - Tale of the Tape Zacks
08:29AM  GlaxoSmithKline (GSK) Stock Gains Today as it Explores ViiV IPO at TheStreet
08:23AM  Merck reports mixed results CNBC
07:18AM  GlaxoSmithKline Earnings Beat Estimates on HIV, Cancer Drugs at Bloomberg
Feb-03-15 05:16PM  Bill would require HPV vaccine for Nevada school enrollment AP
Feb-02-15 04:45PM  Will Glaxo (GSK) Q4 Earnings Suffer from Lower Revenues? - Analyst Blog Zacks
12:48PM  Mylan Makes Deals In Women's Health, Lung Disease at Investor's Business Daily
Jan-30-15 07:45AM  Activis CEO: Innovation vs. acquisition CNBC
Jan-28-15 12:40PM  The $25B GSK-Novartis deal clears major hurdle at American City Business Journals
12:00PM  Novartis (NVS) Up on Earnings and Revenue Beat in Q4 - Analyst Blog Zacks
Jan-26-15 05:10PM  Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog Zacks
09:17AM  GSK expands its portfolio of medicines in the US for patients with asthma and COPD PR Newswire
Jan-23-15 05:50PM  Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog Zacks
04:06PM  Pharmaceutical industry supply chain Market Realist
08:35AM  GSK-Parexel partnership takes first steps following layoffs announcement at American City Business Journals
08:10AM  Box starts trading and Ubers back in Delhi5 things to know today at Fortune
07:42AM  Glaxo tackles fight against Ebola CNBC
Jan-21-15 06:03PM  Investment Bets On Antibiotics To Help Invigorate Investor Portfolios at Forbes
08:35AM  Africa's Consumer Economy at Forbes
Jan-20-15 02:05PM  Stocks: Why earnings matter? CNBC
Jan-16-15 01:50PM  OncoMed Starts Expansion Stage Study for Solid Tumor Drug - Analyst Blog Zacks
Jan-15-15 05:00PM  Isis Pharmaceuticals Earns Milestone Payment from Biogen - Analyst Blog Zacks
10:50AM  Vical Up on Deal with AnGes to Develop Ebola Treatment - Analyst Blog Zacks
Jan-12-15 02:49AM  More Rotavirus Vaccination Means Less Rotavirus at Forbes
Jan-11-15 06:22PM  Shire to buy NPS for $5.2 billion at USA TODAY
Jan-06-15 11:01AM  Gardasil HPV Vaccine Not Linked To Multiple Sclerosis Or Related Diseases at Forbes
Jan-05-15 06:20PM  Hot Biotech Stocks: Isis, Kite Jump On Big Deals at Investor's Business Daily
01:17PM  Isis Pharma To Develop GI Drugs With J&J at Investor's Business Daily
09:05AM  The 2015 Forecast: Another Year To Thrive at Forbes
08:15AM  Chuck Norris Attacks The Pharmaceutical Industry at Forbes
Dec-31-14 05:16PM  Pfizer, Home of Lipitor and Viagra, Lifts Dividend at Investor's Business Daily
01:24PM  CDC warns on flu epidemic CNBC
Dec-30-14 10:00AM  Are Placebos Ethical In Ebola Trials? at Forbes
Dec-29-14 10:38AM  Emerald of the Equator: Indonesia the Next Healthcare Frontier at Forbes
Dec-26-14 12:05PM  BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema at Forbes
Dec-24-14 10:34AM  Alibaba's Attack On Counterfeits; As I've Said Before, Leave Forgeries To The Market at Forbes
07:02AM  Tis the season for buying stocks dumped for tax reasons at MarketWatch
Dec-23-14 04:11PM  BioMarin CEO Sees Big Future For Prosensa Drug at Investor's Business Daily
Dec-19-14 06:49AM  The Ebola Treatment You Haven't Heard Of at Forbes
Dec-18-14 03:11PM  GlaxoSmithKline (GSK) Stock Rises Today on Positive Experimental Shingles Vaccine Trial Results at TheStreet
07:59AM  Glaxo Says Dividend Is Secure as Analysts Question Payout at Bloomberg
07:00AM  Positive Outcome of Phase 3 Study of GSK Shingles Vaccine Containing Agenus Adjuvant GlobeNewswire
Dec-12-14 04:03PM  HFF closes sale of BioMed Realty Trust life sciences facility in Rockville, Maryland Thomson Reuters ONE
Dec-11-14 09:35PM  Stock pro Bhansali: Opportunity abroad in '15 at USA TODAY
03:29PM  Newest HPV Vaccine Protects Against 9 Strains at Forbes
Dec-10-14 08:28AM  GSK Changes Its Drug Sales Practices And R&D Suffers at Forbes
Dec-09-14 07:00AM  How to Trade Foreign Stocks Without Leaving the U.S. Morningstar
Dec-04-14 05:32PM  British drugmaker cutting hundreds of US jobs AP
02:00PM  Array BioPharma Regains Binimetinib Rights from Novartis Zacks
11:29AM  Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative PR Newswire
10:00AM  Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative PR Newswire
Dec-03-14 05:24PM  Rare disease biotech deal CNBC
01:54PM  Glaxo Reorganization to Shift Lots of R&D Work out of North Carolina at The Wall Street Journal
01:52PM  [$$] GlaxoSmithKline to Lay Off Hundreds of U.S. Employees at The Wall Street Journal
Dec-01-14 04:20PM  Dynavax Regains TLR 7/9 Inhibitor DV1179 Rights from Glaxo Zacks
12:31PM  Glaxo Is Said Near Announcing Reorganization, Job Cuts at Bloomberg
12:17PM  Glaxo Plans Hundreds of Layoffs in the U.S. as Part of a Reorganization at The Wall Street Journal
09:24AM  Oil stocks volatile; GlaxoSmithKline job cuts may be in the works; Lions Gate in talks with Chinese conglomerate Hot Stock Minute
08:02AM  American Airlines, Stone Energy, GlaxoSmithKline, Merck and NewLink Genetics highlighted as Zacks Bull and Bear of the Day Zacks
07:34AM  Stocks Fall; Oil prices rebound; Black Friday sales slide Hot Stock Minute
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company's wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company's nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerMar 02Buy18.0692,6741,673,69231,673,853Mar 02 03:45 PM
GLAXOSMITHKLINE PLC10% OwnerAug 11Buy22.66172,6513,912,27230,748,723Aug 11 04:55 PM
GLAXOSMITHKLINE PLC10% OwnerMay 09Buy26.89317,7708,544,83530,576,072May 13 04:43 PM
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM